Jefferies Starts Viking Therapeutic (VKTX) at Buy, 'Strong Mid-Stage Obesity Player with Scarcity Value'
(Updated - March 7, 2024 3:38 AM EST)Jefferies analyst Roger Song initiates coverage on Viking Therapeutic (NASDAQ: VKTX) with a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
